BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30144439)

  • 1. Long non-coding RNA CASC2 in solid tumors: A meta-analysis.
    Liang C; Zhang J; Ge H; Xu Y; Ren S; Yue C; Li G; Wu J
    Clin Chim Acta; 2018 Nov; 486():357-368. PubMed ID: 30144439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Expression of LncRNA Cancer Susceptibility Candidate 2 and its Clinical Significance in Cancer Tissues.
    Zhu ZM; Liu FT; Chen X
    Cell Physiol Biochem; 2018; 46(4):1643-1649. PubMed ID: 29694965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA CRNDE as a potential prognostic biomarker in solid tumors: A meta-analysis.
    Liang C; Zhang B; Ge H; Xu Y; Li G; Wu J
    Clin Chim Acta; 2018 Jun; 481():99-107. PubMed ID: 29501692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: A meta-analysis.
    Liang C; Liu J; Ge H; Xu Y; Li G; Wu J
    Clin Chim Acta; 2018 Sep; 484():91-98. PubMed ID: 29778540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
    Zhong P; Hua H; Chen S; Zhu Z; Xie F
    Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
    Zhang S; Qiu D; Xie X; Shen Y
    BMC Cancer; 2020 Apr; 20(1):343. PubMed ID: 32321469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
    Xue Z; Zhu X; Teng Y
    Mol Med Rep; 2018 Dec; 18(6):5173-5181. PubMed ID: 30320385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the prognostic value of long non-coding RNA CASC15 in human solid tumors utilizing The Cancer Genome Atlas (TCGA) datasets and a meta-analysis.
    Chen W; Qian W; Nie J; Dai M
    Clin Exp Med; 2023 Feb; 23(1):65-78. PubMed ID: 35103883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
    Wang J; Zhong P; Hua H
    Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological significance and prognosis of long noncoding RNA SNHG16 expression in human cancers: a meta-analysis.
    Jiao R; Jiang W; Wei X; Zhang M; Zhao S; Huang G
    BMC Cancer; 2020 Jul; 20(1):662. PubMed ID: 32677912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
    Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA PCAT-1 in human cancers: A meta-analysis.
    Liang C; Qi Z; Ge H; Liang C; Zhang Y; Wang Z; Li R; Guo J
    Clin Chim Acta; 2018 May; 480():47-55. PubMed ID: 29378170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of long non-coding RNA UCA1 in human solid tumors.
    Liu FT; Zhu PQ; Luo HL; Zhang Y; Qiu C
    Oncotarget; 2016 Sep; 7(36):57991-58000. PubMed ID: 27517147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer.
    He X; Liu Z; Su J; Yang J; Yin D; Han L; De W; Guo R
    Tumour Biol; 2016 Jul; 37(7):9503-10. PubMed ID: 26790438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
    Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
    Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value and clinical significance of long noncoding RNA CASC2 in human malignancies: a meta-analysis.
    Cai J; Zuo X; Chen Z; Zhao W; Zhu Y; Zhang Z; Ye X
    Cancer Manag Res; 2018; 10():1403-1412. PubMed ID: 29910638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine Promotes Apoptosis of Colorectal Cancer via Regulation of the Long Non-Coding RNA (lncRNA) Cancer Susceptibility Candidate 2 (CASC2)/AU-Binding Factor 1 (AUF1)/B-Cell CLL/Lymphoma 2 (Bcl-2) Axis.
    Dai W; Mu L; Cui Y; Li Y; Chen P; Xie H; Wang X
    Med Sci Monit; 2019 Jan; 25():730-738. PubMed ID: 30681073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.